Headquarters
10224 FALLS RD, POTOMAC, MD 20854-5008, US
POTOMAC, MD, US
IGC PHARMA, INC
From the company
IGC Pharma is a clinical-stage biotechnology/pharmaceutical company focused on Alzheimer's disease and related dementias. Its lead candidate IGC-AD1, a partial CB1 receptor agonist with anti-inflammatory action, targets agitation in Alzheimer's dementia and has completed enrollment in the Phase 2 CALMA trial. The company also develops AI-driven predictive tools such as MINT-AD and PRISM for early Alzheimer's risk prediction and clinical decision support.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.